142 related articles for article (PubMed ID: 29201440)
21. Association between impaired cutaneous microvascular endothelial function and lectin-like oxidized low-density lipoprotein receptor-1 in patients with coronary slow flow.
Zhao J; Zhang Y; Huang Z; Wu F; Li N; Liang C
Microvasc Res; 2020 May; 129():103984. PubMed ID: 31954703
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of coronary microvascular function and nitric oxide synthase intron 4a/b polymorphism in patients with coronary slow flow.
Ekmekci A; Güngör B; Özcan KS; Abaci N; Ilhan E; Ekmekci SS; Kemaloğlu T; Osmonov D; Ustek D; Eren M
Coron Artery Dis; 2013 Sep; 24(6):461-7. PubMed ID: 23811833
[TBL] [Abstract][Full Text] [Related]
23. Elevated level of plasma homocysteine in patients with slow coronary flow.
Riza Erbay A; Turhan H; Yasar AS; Ayaz S; Sahin O; Senen K; Sasmaz H; Yetkin E
Int J Cardiol; 2005 Jul; 102(3):419-23. PubMed ID: 16004886
[TBL] [Abstract][Full Text] [Related]
24. Relationship of serum salusin beta levels with coronary slow flow.
Akyüz A; Aydın F; Alpsoy Ş; Ozkaramanli Gur D; Guzel S
Anatol J Cardiol; 2019 Sep; 22(4):177-184. PubMed ID: 31584433
[TBL] [Abstract][Full Text] [Related]
25. Impaired coronary blood flow may be related to elevated homocysteine levels in patients with metabolic syndrome.
Alihanoglu YI; Yildiz BS; Özcan EE; Kilic ID; Kuru DS; Taskoylu O; Tanriverdi H; Kaftan HA; Evrengul H
Wien Klin Wochenschr; 2015 Nov; 127(21-22):864-870. PubMed ID: 26377176
[TBL] [Abstract][Full Text] [Related]
26. Coronary blood flow in patients with end-stage renal disease assessed by thrombolysis in myocardial infarction frame count method.
Sobkowicz B; Tomaszuk-Kazberuk A; Kralisz P; Malyszko J; Kalinowski M; Hryszko T; Sawicki R; Dobrzycki S; Musial WJ
Nephrol Dial Transplant; 2010 Mar; 25(3):926-30. PubMed ID: 19875377
[TBL] [Abstract][Full Text] [Related]
27. To show the effect of intermittent fasting during ramadan on endothelial dysfunction via TIMI frame count.
Gocer H; Gunday M; Abusharekh M; Unal M
Niger J Clin Pract; 2021 Jun; 24(6):943-947. PubMed ID: 34121745
[TBL] [Abstract][Full Text] [Related]
28. Increased thrombolysis in myocardial infarction frame count in patients with myocardial infarction and normal coronary arteriogram: a possible link between slow coronary flow and myocardial infarction.
Yetkin E; Turhan H; Erbay AR; Aksoy Y; Senen K
Atherosclerosis; 2005 Jul; 181(1):193-9. PubMed ID: 15939072
[TBL] [Abstract][Full Text] [Related]
29. Effect of Vitamin D and parathyroid hormone levels on the coronary slow-flow phenomenon.
Kalayci B; Karabağ T; Kalaycı S; Erten YT; Köktürk F
Niger J Clin Pract; 2019 Sep; 22(9):1201-1207. PubMed ID: 31489854
[TBL] [Abstract][Full Text] [Related]
30. Elevated endocan concentration is associated with coronary slow flow.
Ye MF; Zhao ZW; Luo YK; Dong XF; Yan YM
Scand J Clin Lab Invest; 2016 Sep; 76(5):345-8. PubMed ID: 27180882
[TBL] [Abstract][Full Text] [Related]
31. Assessment of coronary blood flow in hypertrophic cardiomyopathy using thrombolysis in myocardial infarction frame count method.
Yasar AS; Turhan H; Erbay AR; Karabal O; Bicer A; Sasmaz H; Yetkin E
J Invasive Cardiol; 2005 Feb; 17(2):73-6. PubMed ID: 15687528
[TBL] [Abstract][Full Text] [Related]
32. The lncRNA MALAT1 participates in regulating coronary slow flow endothelial dysfunction through the miR-181b-5p-MEF2A-ET-1 axis.
Zhao C; Zong Z; Zhu Q; Wang Y; Li X; Zhang C; Ma C; Xue Y
Vascul Pharmacol; 2021 Jun; 138():106841. PubMed ID: 33545365
[TBL] [Abstract][Full Text] [Related]
33. Coronary slow flow phenomenon associated with high serum levels of soluble CD40 ligand and urotensin II: a multi-marker approach.
Demir B; Caglar IM; Tureli HO; Pirhan O; Aciksari G; Serkan Çifçi ; Cem Özde ; Gedikbasi A; Zorkun C; Demir E; Karakaya O
Clin Lab; 2014; 60(11):1909-20. PubMed ID: 25648034
[TBL] [Abstract][Full Text] [Related]
34. Low Serum Adropin Levels are Associated with Coronary Slow Flow Phenomenon.
Zhao ZW; Ren YG; Liu J
Acta Cardiol Sin; 2018 Jul; 34(4):307-312. PubMed ID: 30065568
[TBL] [Abstract][Full Text] [Related]
35. The Spontaneous Coronary Slow-Flow Phenomenon: Reversal by Intracoronary Nicardipine.
Mehta HH; Morris M; Fischman DL; Finley JJ; Ruggiero N; Walinsky P; McCarey M; Savage MP
J Invasive Cardiol; 2019 Mar; 31(3):42-45. PubMed ID: 30555052
[TBL] [Abstract][Full Text] [Related]
36. The relationship between coronary slow flow phenomenon and coronary calcium score.
Oz O; Bayram NA; Durmaz T; Keles T; Akcay M; Bozkurt E
Perfusion; 2010 Mar; 25(2):97-102. PubMed ID: 20427414
[TBL] [Abstract][Full Text] [Related]
37. Predictive value of thrombolysis in myocardial infarction frame count for coronary microvascular dysfunction evaluated with an angiography-derived index of microcirculatory resistance in patients with coronary slow flow.
Li M; Su H; Jiang M; Zuo Z; Su Z; Hao L; Yang J; Zhang Z; Wang H; Kong X
Quant Imaging Med Surg; 2022 Oct; 12(10):4942-4952. PubMed ID: 36185054
[TBL] [Abstract][Full Text] [Related]
38. Comparative efficacy of primary angioplasty with stent implantation and thrombolysis in restoring basal coronary artery flow in acute ST segment elevation myocardial infarction: quantitative assessment using the corrected TIMI frame count.
Vrachatis AD; Alpert MA; Georgulas VP; Nikas DJ; Petropoulou EN; Lazaros GI; Michelakakis NA; Karavidis AI; Lakoumentas JA; Stergiou L; Zacharoulis AA
Angiology; 2001 Mar; 52(3):161-6. PubMed ID: 11269778
[TBL] [Abstract][Full Text] [Related]
39. Reduced circulating endothelial progenitor cells in the coronary slow flow phenomenon.
Li Q; Han J; Chen H; Mo X
Coron Artery Dis; 2013 Jan; 24(1):6-10. PubMed ID: 23196377
[TBL] [Abstract][Full Text] [Related]
40. [The association of coronary slow flow with time to peak systolic strain].
Aksakal E; Islamoğlu Y; Simşek Z; Elbey MA; Sevimli S; Arslan S; Gündoğdu F; Senocak H
Turk Kardiyol Dern Ars; 2011 Jan; 39(1):29-34. PubMed ID: 21358228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
